GILD Gilead Sciences Options Ahead of Earnings

If you haven`t bought GILD on the Remdesivir approval:

Then analyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week,
I would consider purchasing the 80usd strike price in the money Calls with
an expiration date of 2024-1-19,
for a premium of approximately $4.25.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.

Looking forward to read your opinion about it.